$250 | Single User
$500 | Site License
$750 | Global License

Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 06-12-2018]

Published by Global Data: 06 Dec 2018 | 228109 | In Stock

Introduction

Summary

Leadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matulane and revcovi, among others. It also offers services including patient support, discovery and development of novel medicines for the unmet needs of patients with rare diseases. Leadiant Biosciences conducts research and development for the treatment of cerebrotendinous xanthomatosis, adenosine deaminase severe combined immunodeficiency, necrotizing enterocolitis and GNE myopathy. The company markets its products through a network of distributors in the US and abroad. Leadiant Biosciences is headquartered in Gaithersburg, Maryland, the US.

Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 06-12-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    Leadiant Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

    Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

    Partnerships 11

    TRPharm and Leadiant Biosciences Enter into Distribution Agreement 11

    Licensing Agreements 12

    Sigma-Tau Pharma Enters into Licensing Agreement with Crosscare for Colief 12

    Asset Transactions 13

    Jazz Pharma Acquires Defibrotide from Sigma-Tau Pharma for USD250 Million 13

    Acquisition 15

    Sigma-Tau May Sell Sigma-Tau Pharma 15

    Leadiant Biosciences Inc - Key Competitors 16

    Leadiant Biosciences Inc - Key Employees 17

    Leadiant Biosciences Inc - Locations And Subsidiaries 18

    Head Office 18

    Recent Developments 19

    Other Significant Developments 19

    Feb 28, 2017: Sigma-Tau Pharmaceuticals Changes Name to Leadiant Biosciences And Reaffirms its Commitment to Rare Disease Communities 19

    Appendix 20

    Methodology 20

    About GlobalData 20

    Contact Us 20

    Disclaimer 20

List Of Tables
in Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 06-12-2018]

List of Tables

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Leadiant Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

TRPharm and Leadiant Biosciences Enter into Distribution Agreement 11

Sigma-Tau Pharma Enters into Licensing Agreement with Crosscare for Colief 12

Jazz Pharma Acquires Defibrotide from Sigma-Tau Pharma for USD250 Million 13

Sigma-Tau May Sell Sigma-Tau Pharma 15

Leadiant Biosciences Inc, Key Competitors 16

Leadiant Biosciences Inc, Key Employees 17

List Of Figures, Charts and Diagrams
in Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 06-12-2018]

List of Figures

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

228109 | GDPH189891D

Number of Pages

20

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryLeadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals, a subsid...
17 Sep 2018 by Global Data USD $250 More Info
Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryLeadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals, a subsid...
23 Apr 2018 by Global Data USD $250 More Info
Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryLeadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals, a subsid...
13 Mar 2018 by Global Data USD $250 More Info
Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryLeadiant Biosciences Inc (Leadiant Biosciences) a subsidiary of Sigma-Tau SpA is a pharmaceut...
28 Nov 2017 by Global Data USD $250 More Info
Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryLeadiant Biosciences Inc (Leadiant Biosciences) a subsidiary of Sigma-Tau SpA is a pharmaceut...
28 Aug 2017 by Global Data USD $250 More Info
Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryLeadiant Biosciences Inc (Leadiant Biosciences) a subsidiary of Sigma-Tau SpA is a pharmaceut...
26 Apr 2017 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 06-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data